Sign Up Now
Get instant access to over 1 million+ study documents
OR
Already registered? click here to login
By creating your account, you agree to our terms of service, privacy policy and student honor code.
Door Balloon
Door-to-Balloon Time
The quality indicator examined herein is the measurement known as door-to-balloon time, which is a defined element in emergency cardiac care that refers to the time from patient entrance to an emergency department to the time a catheter wire passes the lesion responsible for a myocardial infarction. An increase in door-to-balloon time carries with it an increased risk for tissue damage and thus more permanent complications and detriments to patients' health, and thus certain standards have been set in an effort to promote best practices and measure the efficacy of emergency department treatment of myocardial infarctions. The current recommendation for door-to-balloon time is ninety minutes or less, and this is a number that should be strived for with every patient, not simply as an average for the emergency treatment of myocardial...
Using door-to-balloon time as a measure of care efficacy and quality provides a direct and quantifiable method that can be easily tracked over time and in response to various improvement efforts and changes to policy or practice.
According to the six observations included in this chart, the emergency department in question appears to be providing excellent care as measured by door-to-balloon time, with the longest time measured (sixty-four minutes) still substantially lower than the current recommended maximum time of ninety minutes -- only two thirds of this time, in fact. The shortest tome observed for door-to-balloon achievement, twenty-five minutes, is especially impressive and was likely of…
Myocardial Infarction According to the Centers for Disease Control and Prevention (CDC, 2006), each year approximately 1.2 million Americans suffer from myocardial infarction (heart attack) each year. 40% of these people who a have heart attack will die from it. This equates to a person having a heart attack every 34 seconds, and a person dying from a heart attack every minute. Heart disease is the leading cause of death in
MI Case Study: Myocardial Infarction At 10:05 A.M., the blockage that had been silently growing in Paul Parker's left coronary artery made its sinister presence known. The 54-year-old accounting executive had arrived with his family at the Denver zoo feeling fine, but suddenly a dull ache started in the center of his chest and he became nauseated. At first he brushed it off as the aftereffects of a company dinner the night
Myocardial Infarction Risk for Women with Breast Cancer: Annotated Bibliography Abdel-Qadir, H., Amir, E., Fischer, H. D., Fu, L., Austin, P. C., Harvey, P. J., ... & Anderson, G. M. (2016). The risk of myocardial infarction with aromatase inhibitors relative to tamoxifen in post-menopausal women with early stage breast cancer. European Journal of Cancer, 68, 11-21. The rationale for this study was that a gap in the literature existed with respect to the possibility
Acute Myocardial Infarction PATHOPHYSIOLOGICAL PROCESS TEMPLATE DISEASE: Acute Myocardial Infarction is a common disease with very grave consequences in morbidity, mortality and cost to the society (Boersma et.al, 2003) It has become the leading cause of death in the developed world. It has been estimated that about 450,000 people die from coronary disease per year in the United States. Myocardial infarction primarily occurs when the blood supply to the heart is compromised. Just like
Health Care Services for Myocardial Infarction: Myocardial Infarction (MI) is commonly known as Acute Myocardial Infarction (AMI) is a heart attack disease in which blood supply to a part of the heart is interrupted resulting in ultimate irreversible damage and cell death in that part of the heart (Khan, 2010). As one of cardiovascular diseases, myocardial infarction can be regarded as one of the leading causes of death for men
5% while 70.5% took Aspirin within six hours after reaching hospital and 76.5% of patients admitted in the NICVD were receiving Aspirin therapy." (Jaiwa, 2006, p.1) Jaiwa reports a more recent study that states findings that out of 52 patients with chest pain only 13 patients or 25% of the 52 received aspirin. The stated reason for not giving aspirin to the other 39 patients included that "chest pain was not